Charles Ryan and Alicia Morgans encourage participation in a 6 minute (survey) study available on UroToday.com, titled the Global vs. Expert Consensus in the Management of Advanced Prostate Cancer Study, a questionnaire intended to determine the global consensus among all physicians treating patients with advanced prostate cancer. The aim is to further understand global patterns of care in advanced prostate cancer. The target participants are all clinicians who see prostate cancer patients on a regular basis and are involved in treatment decision making. 

Biographies:

Charles J. Ryan, MD, the President and Chief Executive Officer of The Prostate Cancer Foundation (PCF), the world’s leading philanthropic organization dedicated to funding life-saving prostate cancer research. Charles J. Ryan is an internationally recognized genitourinary (GU) oncologist with expertise in the biology and treatment of advanced prostate cancer. Dr. Ryan joined the PCF from the University of Minnesota, Minneapolis, where he served as Director of the Hematology, Oncology, and Transplantation Division in the Department of Medicine. He also served as Associate Director for Clinical Research in the Masonic Cancer Center and held the B.J. Kennedy Chair in Clinical Medical Oncology.

Alicia Morgans, MD, MPH, is an Associate Professor of Medicine in the Division of Hematology/Oncology at the Northwestern University Feinberg School of Medicine in Chicago, Illinois.

Related Content: 

PARTICIPATE IN THE STUDY: Global vs. Expert Consensus in the Management of Advanced Prostate Cancer

Read: Conference Coverage - Advanced Prostate Cancer Consensus Conference (APCCC 2019)

Access: All Advanced Prostate Cancer Consensus Conference Video Coverage

Read: The 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer